- Previous Close
1.2900 - Open
1.3000 - Bid --
- Ask --
- Day's Range
1.3000 - 1.3200 - 52 Week Range
1.1900 - 2.1100 - Volume
348 - Avg. Volume
3,936 - Market Cap (intraday)
51.324M - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.5400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.97
Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.
www.affluentmedical.comRecent News: AFME.PA
View MorePerformance Overview: AFME.PA
Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AFME.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AFME.PA
View MoreValuation Measures
Market Cap
50.54M
Enterprise Value
66.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.94
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.51%
Return on Equity (ttm)
-52.40%
Revenue (ttm)
1.29M
Net Income Avi to Common (ttm)
-17.04M
Diluted EPS (ttm)
-0.5400
Balance Sheet and Cash Flow
Total Cash (mrq)
915k
Total Debt/Equity (mrq)
67.15%
Levered Free Cash Flow (ttm)
-1.44M